Lending Formulas definition

Lending Formulas means, collectively, the percentages set forth ---------------- in Section 3.1(a) hereof with respect to Eligible Accounts and the various types or categories of Eligible Inventory.
Sample 1
Lending Formulas means the percentages with respect to Eligible Accounts and Eligible Inventory set forth in the definition of the term Borrowing Base contained herein.
Sample 1Sample 2
Lending Formulas means, collectively, the Operating Leases Lending Formula, the Capital Leases Lending Formula, the Finished Goods Inventory Lending Formula, the Long Term Receivables Lending Formula and the Real Property Lending Formula."
Sample 1Sample 2

Examples of Lending Formulas in a sentence

  • In determining whether to reduce or otherwise revise the Lending Formulas, Lender may consider events, conditions, contingencies or risks which are also considered in determining Eligible Operating Leases or Eligible Capital Leases or in establishing Availability Reserves.

  • In determining whether to reduce any of the Lending Formulas, Agent may consider events, conditions, contingencies or risks which are also considered in determining Eligible Accounts, Eligible Inventory or in establishing reserves as provided in Section 3.5 hereof.

  • In determining whether to reduce any of the Lending Formulas, Lender may consider events, conditions, contingencies or risks which are also considered in determining Eligible Accounts, Eligible Inventory or in establishing reserves as provided in Section 2.4. Borrowers may from time to time borrow, repay and reborrow Loans made to it in accordance with the terms hereof.

  • Lender hereby agrees not to change the Lending Formulas in effect under the Loan Agreement as of the effective date hereof for a period of sixty (60) days from the effective date hereof, provided, that, no Draw Event (as such term is defined in the Junior Participation Agreement) has occurred.

  • In determining whether to reduce any of the Lending Formulas, Agent may consider events, conditions, contingencies or risks which are also considered in determining Eligible Accounts, Eligible Inventory or in establishing reserves as provided in Section 3.3. Borrower may from time to time borrow, repay and reborrow Loans in accordance with the terms hereof.


More Definitions of Lending Formulas

Lending Formulas means, collectively, the Eligible Accounts Lending Formula, the Operating Leases Lending Formula, the Capital Leases Lending Formula, the Finished Goods Inventory Lending Formula, the Long Term Receivables Contract Lending Formula and the Real Property Lending Formula.
Sample 1Sample 2
Lending Formulas means the percentages set forth in Section 3.1 hereof with respect to Eligible Accounts and Eligible Inventory.
Sample 1Sample 2
Lending Formulas means, collectively, the Operating Leases Lending Formula and the Capital Leases Lending Formula.
Sample 1
Lending Formulas means the lending formulas set forth in Sections 2.1(a)(i) and (ii) and Section 2.2 of the Loan Agreement, without giving effect to this Amendment and the Supplemental Credit Facility, as the same now exist or may hereafter be adjusted by Lender pursuant to the Loan Agreement. (xi) " R & R" shall mean R & R Vista, a general partnership organized under the laws of the state of Oregon, and its successors and assigns. (xii) "Standby Letter of Credit" shall mean the Irrevocable Standby Letter of Credit, dated of even date herewith, issued by Xxxxx Fargo Bank for the account of R & R and for the benefit of Lender in the original face amount of $10,000,000.
Sample 1

Related to Lending Formulas

  • Combination Products means COBI Combination Products, EVG Combination Products, TDF Combination Products, TAF Combination Products and Quad Product.

  • Therapeutically equivalent drug products means drug products that contain the same active ingredients and are identical in strength or concentration, dosage form, and route of administration and that are classified as being therapeutically equivalent by the U.S. Food and Drug Administration pursuant to the definition of "therapeutically equivalent drug products" set forth in the most recent edition of the Approved Drug Products with Therapeutic Equivalence Evaluations, otherwise known as the "Orange Book."

  • Corresponding Component As identified in the Preliminary Statement with respect to any Class of Non-Vertically Retained Principal Balance Certificates or Lower-Tier Regular Interest.

  • New Products means any product which is not an Enhanced Product or 2 Existing Product but which is substantially similar to an Existing Product with respect to design and function and possesses reasonable performance improvements. If Company desires to purchase an Enhanced or New Product(s) from Supplier, Company shall so notify Supplier and provide Supplier the opportunity to manufacture such Enhanced or New Product(s), subject to the following conditions and procedures.

  • Bearing components means the bearing element, retainer, inner race, or outer race.

  • Financial Product means any securities, futures contracts or leveraged foreign exchange contracts as defined under the SFO. Regarding “leveraged foreign exchange contracts”, it is only applicable to those traded by persons licensed for Type 3 regulated activity.

  • Technique factors means the following conditions of operation:

  • Hemp products means all products made from industrial hemp,

  • Nondesignated country end product means any end product that is not a U.S.-made end product or a designated country end product.

  • Product means any deliverable under the Contract, which may include commodities, services, technology or software.

  • Financial Products “Development Services”; “Target Market”; “Investment Areas”; and “Targeted Populations” have the meanings ascribed to such terms in 12 C.F.R. 1805.104.

  • Combination Product means any combination of the Product with one (1) or more other active ingredients, products or services that is not the Product, where such products are sold either as a fixed dose/unit or as separate doses/units in a single package for a single price.

  • Competitive Products shall include any product or service that directly or indirectly competes with, is substantially similar to, or serves as a reasonable substitute for, any product or service in research, development or design, or manufactured, produced, sold or distributed by the Company;

  • Reference biological product means the single biological product licensed pursuant to 42 U.S.C.

  • Other Products means all products and services, other than an Advance, Credit Product or Derivative Transaction, offered by the Bank to any Obligor from time to time, including correspondent banking services, mortgage purchase programs and affordable housing and community investment products and services.

  • Portfolios means the constituent series of the Fund, but for purposes of this Section 14.1 shall not include Portfolios excepted from the requirements of paragraph (a) of Rule 22c-2 by paragraph (b) of Rule 22c-2.

  • Products means information resources technologies that are, or are related to, EIR.

  • available techniques means those techniques which have been developed on a scale which allows implementation in the relevant industrial sector, in the economically and technically viable conditions, taking into consideration the cost and advantages, whether or not the techniques are used or produced inside the United Kingdom, as long as they are reasonably accessible to the operator;

  • Competitive Products or Services means, as of any time, those products or services of the type that any of the Bank Entities is providing, or is actively preparing to provide, to its customers.

  • Related Financial Product means any financial product which references directly or indirectly the Preference Shares.

  • Indices means, subject to Adjustment Provisions, the following indices (and each an Index)

  • Processes “Processing,” “Processed” means any operation or set of operations which is performed on data or sets of data, whether or not by automated means, such as collection, recording, organization, structuring, storage, adaptation or alteration, retrieval, consultation, use, disclosure by transmission, dissemination, or otherwise making available, alignment or combination, restriction, erasure, or destruction.

  • Performance Indicators means the indicators for Project monitoring and evaluation set forth in the Operational Manual.

  • Programs refers to (a) the software owned or distributed by Oracle that You have ordered under Schedule P, (b) Program Documentation and (c) any Program updates acquired through technical support. Programs do not include Integrated Software or any Operating System or any software release prior to general availability (e.g., beta releases).

  • Marketing Information means marketing studies, marketing analyses, and similar research and information designed to identify potential customers and business relationships.

  • Drug Substance means an active ingredient that is intended to furnish pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease or to affect the structure or any function of the human body, but does not include intermediates used in the synthesis of such ingredient.